CONTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 233
EU - Europa 50
AS - Asia 29
AF - Africa 1
Totale 313
Nazione #
US - Stati Uniti d'America 230
SG - Singapore 16
IT - Italia 14
FI - Finlandia 10
SE - Svezia 10
IN - India 8
CN - Cina 5
DE - Germania 4
UA - Ucraina 4
GB - Regno Unito 3
BG - Bulgaria 2
RU - Federazione Russa 2
CA - Canada 1
CU - Cuba 1
IE - Irlanda 1
MX - Messico 1
TG - Togo 1
Totale 313
Città #
Fairfield 33
Wilmington 19
Chandler 17
Cambridge 16
Dearborn 16
Woodbridge 16
Ashburn 14
Houston 12
Seattle 12
Singapore 11
Santa Clara 9
Rome 7
San Paolo di Civitate 6
Ann Arbor 5
Helsinki 5
Lawrence 5
Plano 5
Princeton 5
Boston 3
Fremont 3
London 2
Millbury 2
Sofia 2
Andover 1
Beijing 1
Bühl 1
Cattolica 1
Dublin 1
Falkenstein 1
Guangzhou 1
Havana 1
Jacksonville 1
Jinan 1
Kunming 1
Lomé 1
Mannheim 1
Mexico City 1
Norwalk 1
San Diego 1
San Jose 1
Toronto 1
Wuhan 1
Totale 244
Nome #
Rosuvastatin pre-treatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis. The ROMA trial. 82
Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE Experience (The RUDI Registry) 70
Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial 68
Evidence from the Resorbable-polymer stent versus Unresorbable-polymer stent Deployment for coronary Intervention: (RUDI-2) registry. 59
Frequency of peripheral CD4+ CD25+ regulatory T cells is reduced in patients with ST-elevation myocardial infarction after placlitaxel-eluting stent implantation during primary PCI 40
Totale 319
Categoria #
all - tutte 939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059 0 0 0 0 0 20 14 9 9 3 1 3
2020/202112 0 4 0 1 0 1 0 3 2 0 1 0
2021/202248 0 3 7 1 5 1 0 8 2 3 7 11
2022/202365 11 21 4 4 2 2 4 2 7 0 5 3
2023/202420 2 5 0 2 1 3 0 1 0 2 1 3
2024/202531 1 4 5 1 8 12 0 0 0 0 0 0
Totale 319